Published in Infect Immun on October 01, 1990
Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1. Infect Immun (1992) 1.88
Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev (1998) 1.81
Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect Immun (1993) 1.77
Inactivation of the gene encoding surface protein SspA in Streptococcus gordonii DL1 affects cell interactions with human salivary agglutinin and oral actinomyces. Infect Immun (1993) 1.68
Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect Immun (1991) 1.56
Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect Immun (2005) 1.54
A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans. Infect Immun (1993) 1.30
The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol Microbiol (2010) 1.30
Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. Emerg Infect Dis (1999) 1.29
Identification of monoclonal antibody-binding domains within antigen P1 of Streptococcus mutans and cross-reactivity with related surface antigens of oral streptococci. Infect Immun (1991) 1.21
Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect Immun (2006) 1.14
Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect Immun (1991) 1.05
Passive transfer of immunoglobulin Y antibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infect Immun (2001) 1.03
Antigenic characterization of fimbria preparations from Streptococcus mutans isolates from caries-free and caries-susceptible subjects. Clin Diagn Lab Immunol (1997) 1.00
Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood. Infect Immun (1994) 1.00
Characterization of preparations enriched for Streptococcus mutans fimbriae: salivary immunoglobulin A antibodies in caries-free and caries-active subjects. Clin Diagn Lab Immunol (1995) 0.97
A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS One (2011) 0.97
Orally administered P22 phage tailspike protein reduces salmonella colonization in chickens: prospects of a novel therapy against bacterial infections. PLoS One (2010) 0.95
Characterization of the conformational epitope of Guy's 13, a monoclonal antibody that prevents Streptococcus mutans colonization in humans. Infect Immun (2003) 0.93
Contribution of the alanine-rich region of Streptococcus mutans P1 to antigenicity, surface expression, and interaction with the proline-rich repeat domain. Infect Immun (2004) 0.92
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS One (2012) 0.91
Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans. Infect Immun (2000) 0.89
A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response. Vaccine (2011) 0.87
Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope. J Immunol (2009) 0.86
Plant antibodies for immunotherapy. Plant Physiol (1995) 0.83
Defining antibody targets in Streptococcus oralis infection. Infect Immun (1996) 0.82
Novel technologies for the prevention and treatment of dental caries: a patent survey. Expert Opin Ther Pat (2010) 0.81
Similar proportions of immunoglobulin A1 (IgA1) protease-producing streptococci in initial dental plaque of selectively IgA-deficient and normal individuals. Infect Immun (1993) 0.80
Production of Monoclonal Antibodies Specific to FimA of Porphyromonas gingivalis and Their Inhibitory Activity on Bacterial Binding. Immune Netw (2009) 0.77
Structural insight in the inhibition of adherence of F4 fimbriae producing enterotoxigenic Escherichia coli by llama single domain antibodies. Vet Res (2015) 0.76
Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach. BMC Biotechnol (2005) 0.75
PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand (1963) 15.52
PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand (1964) 15.31
Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev (1980) 13.40
Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component. Infect Immun (1980) 4.36
Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction. J Exp Med (1957) 3.81
Wall-associated protein antigens of Streptococcus mutans. J Gen Microbiol (1979) 3.62
Construction and characterization of isogenic mutants of Streptococcus mutans deficient in major surface protein antigen P1 (I/II). Infect Immun (1989) 3.06
Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol (1978) 3.03
Establishment of Streptococcus sanguis in the mouths of infants. Arch Oral Biol (1970) 2.75
Genetic analysis of Streptococcus mutans virulence. Curr Top Microbiol Immunol (1985) 2.35
Biochemical and immunological differences between hydrophobic and hydrophilic strains of Streptococcus mutans. Infect Immun (1984) 2.17
A biochemical scheme for the separation of the five varieties of Streptococcus mutans. Arch Oral Biol (1974) 2.16
Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c. Infect Immun (1990) 1.95
Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries. Infect Immun (1985) 1.92
Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect Immun (1987) 1.70
Immunisation with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet (1980) 1.61
A radioimmunoassay for serum and gingival crevicular fluid antibodies to a purified protein of Streptococcus mutans. Clin Exp Immunol (1981) 1.56
Separation and characterization of a protein antigen from cells of Streptococcus mutans. J Gen Microbiol (1981) 1.44
Ultrastructural localization of protein antigens I/II and III in Streptococcus mutans. Infect Immun (1983) 1.42
A selective medium for the two major subgroups of the bacterium Streptococcus mutans isolated from human dental plaque and saliva. Arch Oral Biol (1983) 1.23
Recognition of carbohydrate and protein epitopes by monoclonal antibodies to a cell wall antigen from Streptococcus mutans. Infect Immun (1987) 1.12
Specificity of monoclonal antibodies in local passive immunization against Streptococcus mutans. Clin Exp Immunol (1989) 1.10
Studiey on the mechanism of the long chain phenomenon of group A streptococci. J Exp Med (1963) 1.08
Isolation and characterization of Streptococcus mutans mutants with altered cellular morphology or chain length. Infect Immun (1982) 1.07
Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans. Infect Immun (1987) 1.05
Support for and implications of the specific plaque hypothesis. Scand J Dent Res (1985) 0.98
Characterisation of monoclonal antibodies to common protein epitopes on the cell surface of Streptococcus mutans and Streptococcus sobrinus. Oral Microbiol Immunol (1989) 0.96
Lysozyme-mediated de-chaining of Streptococcus mutans and its antibacterial significance in an acidic environment. J Dent Res (1985) 0.85
Why are doctors so unhappy? There are probably many causes, some of them deep. BMJ (2001) 22.59
Evidence based medicine. BMJ (1995) 21.24
What clinical information do doctors need? BMJ (1996) 16.23
Three-dimensional structure of myosin subfragment-1: a molecular motor. Science (1993) 14.90
Informed consent: the intricacies. BMJ (1997) 13.97
An ethical code for everybody in health care. BMJ (1998) 9.13
All changed, changed utterly. British medicine will be transformed by the Bristol case. BMJ (1998) 9.08
Growing pressure on BMJ's obituaries. BMJ (1995) 8.92
Authorship: time for a paradigm shift? BMJ (1997) 8.90
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
The failings of NICE. BMJ (2000) 8.50
The future of medicine. BMJ (1994) 8.14
A good death. An important aim for health services and for us all. BMJ (2000) 8.03
Using evidence to inform health policy: case study. BMJ (2001) 7.99
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Time to face up to research misconduct. BMJ (1996) 7.66
Beyond conflict of interest. Transparency is the key. BMJ (1998) 7.63
Meeting the information needs of health workers in developing countries. BMJ (1997) 6.31
Medicine's core values. BMJ (1994) 5.93
Revel in electronic and paper media. BMJ (2000) 5.82
The GMC on performance. BMJ (1992) 5.57
Informed consent: edging forwards (and backwards) BMJ (1998) 5.52
PubMed Central: creating an Aladdin's cave of ideas. BMJ (2001) 5.49
Does Britain need an academy of medicine? BMJ (1996) 5.47
Effect of open peer review on quality of reviews and on reviewers' recommendations: a randomised trial. BMJ (1999) 5.45
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Rationing: the search for sunlight. BMJ (1992) 5.26
Publishing information about patients. BMJ (1995) 5.19
The future of healthcare systems. BMJ (1997) 5.14
Prejudice against doctors and students from ethnic minorities. Br Med J (Clin Res Ed) (1987) 5.12
The war on drugs. BMJ (1996) 5.11
Global information flow. BMJ (2000) 5.09
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
What makes a good reviewer and a good review for a general medical journal? JAMA (1998) 5.01
Where is the wisdom...? BMJ (1991) 4.85
Medicine and the marginalised. They deserve the best, not the poorest, care. BMJ (2000) 4.80
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
Review of death certificates to assess completeness of AIDS case reporting. Public Health Rep (1987) 4.66
X-ray structures of the myosin motor domain of Dictyostelium discoideum complexed with MgADP.BeFx and MgADP.AlF4-. Biochemistry (1995) 4.64
Time to register randomised trials. The case is now unanswerable. BMJ (1999) 4.55
PFI: perfidious financial idiocy. A "free lunch" that could destroy the NHS. BMJ (1999) 4.54
Moving beyond journals: the future arrives with a crash. BMJ (1999) 4.49
Rationing: the debate we have to have. BMJ (1995) 4.47
Time to redefine authorship. BMJ (1996) 4.39
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component. Infect Immun (1980) 4.36
Animal research: the need for a middle ground. BMJ (2001) 4.34
Conflict of interest and the BMJ. BMJ (1994) 4.34
Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature (1999) 4.32
Prison medicine: beginning again. BMJ (1992) 4.29
Measuring the social impact of research. BMJ (2001) 4.17
The case for structuring the discussion of scientific papers. BMJ (1999) 4.16
Peer review: reform or revolution? BMJ (1997) 4.13
Profile of the GMC: The day of judgment comes closer. BMJ (1989) 4.10
Managing the clinical performance of doctors. A coherent response to an intractable problem. BMJ (1999) 4.08
Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA (1998) 4.03
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int (2006) 3.96
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol (2001) 3.92
Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89
Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell (1979) 3.78
Profile of the GMC. 1978 and all that. BMJ (1989) 3.76
"Taken from this place and hanged by the neck...". BMJ (1991) 3.72
The rights of patients in research. BMJ (1995) 3.68
All doctors are problem doctors. BMJ (1997) 3.67
The BMJ's website scales up. BMJ (1998) 3.67
Publishing research supported by the tobacco industry. BMJ (1996) 3.65
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
How best to organise acute hospital services? BMJ (2001) 3.63
Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61
Netprints: the next phase in the evolution of biomedical publishing. BMJ (1999) 3.60
Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant (2006) 3.58
GMC: approaching the abyss. BMJ (2001) 3.52
Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature (1990) 3.48
The deliberate misdiagnosis of major depression in primary care. Arch Fam Med (1994) 3.46
Pleasing both authors and readers. A combination of short print articles and longer electronic ones may help us do this. BMJ (1999) 3.44
New government, same narrow vision. BMJ (1998) 3.40
Don't treat shackled patients. BMJ (1997) 3.40
The woolwich and erith project. Planning a community health service. Lancet (1966) 3.34
Almost no evidence exists that the internet harms health. BMJ (2001) 3.31
Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell (1979) 3.26
Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr (1990) 3.24
The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun (1976) 3.22
Opening up BMJ peer review. BMJ (1999) 3.21
Doctors, unethical treatments, and turning a blind eye. BMJ (1989) 3.13
Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med (1998) 3.11
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst (1999) 3.07
Reconfiguring acute hospital services. No easy answers, but there are principles we should follow. BMJ (1999) 3.07
Authorship is dying: long live contributorship. BMJ (1997) 3.07
Hamster health care. BMJ (2001) 3.06
Promoting research into peer review. BMJ (1994) 3.05
Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol (1978) 3.03
Rationing health care: moving the debate forward. BMJ (1996) 3.03
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res (2000) 3.01
GMC in the dock again. BMJ (1993) 2.99
Maintaining the integrity of the scientific record. BMJ (2001) 2.98
Patients with schizophrenia who smoke. Private disaster, public resource. Br J Psychiatry (2000) 2.97
Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease. Arch Oral Biol (1970) 2.95
Altered relation of two collagen types in osteogenesis imperfecta. N Engl J Med (1977) 2.93
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (1988) 2.93
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91